Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

Dixon, John B., Bhathal, Prithi S., Hughes, Norman R., O'Brien, Paul E.·2004·Hepatology

Cited by (724)

Items 301–400 of 724

  1. Surgical Treatment for Obesity and Its Impact on Non-alcoholic Steatohepatitis
    John B. Dixon · 2007 · Clinics in Liver Disease
  2. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Kelli A. Lytle, Donald Β. Jump · 2016 · PLoS ONE
  3. Novel Pharmacotherapy Options for NASH
    Vlad Ratziu · 2016 · Digestive Diseases and Sciences
  4. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
    Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kyum Kim, Joo Sung Kim · 2016 · Liver International
  5. Induced hypothyroidism accelerates the regression of liver fibrosis in rats
    Rafael Bruck, Sigal Weiss, Alexandra Traister, Isabel Zvibel, Hussein Aeed, Zamir Halpern, Ran Oren · 2006 · Journal of Gastroenterology and Hepatology
  6. Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
    Kenichiro Yasutake, Motoyuki Kohjima, Manabu Nakashima, Kazuhiro Kotoh, Makoto Nakamuta, Munechika Enjoji · 2012 · Gastroenterology Research and Practice
  7. Ultrasound elastography in patients with fatty liver disease
    Luiza de Campos Moreira da Silva, J. Oliveira, Sandra Tochetto, Claudia Pinto Marques Souza de Oliveira, Rosa Maria Silveira Sigrist, Maria Cristina Chammas · 2019 · Radiologia Brasileira
  8. Medical Treatment of Non-alcoholic Steatohepatitis
    Abdurrahman Kadayıfçı, Raphael B. Merriman, Nathan M. Bass · 2007 · Clinics in Liver Disease
  9. Targeted proteomics reveals strain‐specific changes in the mouse insulin and central metabolic pathways after a sustained high‐fat diet
    Eduard Sabidó, Yibo Wu, Lucía Bautista Borrego, Thomas Porstmann, Ching-Yun Chang, Olga Vitek, Markus Stoffel, Ruedi H. Aebersold · 2013 · Molecular Systems Biology
  10. Treatment of patients with non-alcoholic fatty liver disease: Current views and perspectives
    Alessandro Federico, M. Trappoliere, C. Loguercio · 2006 · Digestive and Liver Disease
  11. Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease
    Geraldine Ooi, Paul Robert Burton, Lisa Doyle, John M. Wentworth, Prithi S. Bhathal, Ken A. Sikaris, Michael Alexander Cowley, Stuart Keith Roberts, William W. Kemp, Arul Earnest et al. · 2016 · Obesity Surgery
  12. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis
    Vlad Ratziu, Marwan Ghabril, Manuel Romero‐Gómez, Gianluca Svegliati‐Baroni · 2018 · Transplantation
  13. Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels
    Ahmed Salman, Ahmed Abd El Aal Sultan, Ahmed Abdallah, Ahmed Abdelsalam, Hani Maurice Sabri Mikhail, Mohamed Sabry Tourky, Mahmoud Gouda Omar, Ahmed Youssef, Reham Abdelghany Ahmed, Hesham Elkassar et al. · 2020 · Journal of Gastroenterology and Hepatology
  14. Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease
    Misael Uribe, Daniel Zamora‐Valdés, Mucio Moreno-Portillo, Luisa Bermejo-Martínez, Raúl Pichardo-Bahena, Héctor Alfredo Baptista González, Guadalupe Ponciano‐Rodríguez, Martha H. Uribe, Roberto Medina‐Santillán, Nahúm Méndez‐Sánchez · 2008 · Annals of Hepatology
  15. Monitoring Fatty Liver Disease with MRI Following Bariatric Surgery: A Prospective, Dual-Center Study
    Pooler, B. Dustin, Wiens, Curtis N., McMillan, Alan, Artz, Nathan S., Schlein, Alexandra, Covarrubias, Yesenia, Hooker, Jonathan, Schwimmer, Jeffrey B., Funk, Luke M., Campos, Guilherme M. et al. · 2019 · Radiology
  16. Review article: the treatment of non‐alcoholic steatohepatitis with thiazolidinediones
    Hendrik Reynaert, Albert E. Geerts, Jean Henrion · 2005 · Alimentary Pharmacology & Therapeutics
  17. Rapid acquisition technique for MR elastography of the liver
    Suresh K. Chamarthi, Brian D. Raterman, Ria Mazumder, Anthony J. Michaels, Veeral M. Oza, James A. Hanje, Bradley D. Bolster, Ning Jin, Richard D. White, Arunark Kolipaka · 2014 · Magnetic Resonance Imaging
  18. Approach to the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease
    Janus P. Ong, Zobair M. Younossi · 2005 · Clinics in Liver Disease
  19. Non-Alcoholic Fatty Liver Disease, an Overview.
    Asia Muhammad · 2019 · PubMed Central
  20. Prevalence of NAFLD in Healthy and Young Male Individuals
    Asif Niaz, Zafar Ali, Shaista Nayyar, Naureen Fatima · 2011 · ISRN Gastroenterology
  21. Non-alcoholic fatty liver disease resolution following sleeve gastrectomy
    Algooneh, Ardeshir, Almazeedi, Sulaiman, Al-Sabah, Salman, Ahmed, Maha, Othman, Feras · 2016 · Surgical Endoscopy
  22. The Incapacity of the Surgeon to Identify NASH in Bariatric Surgery Makes Biopsy Mandatory
    Antônio Roberto Franchi Teixeira, Marta Bellodi‐Privato, José Barreto Campello Carvalheira, Victor Fernando Pilla, José Carlos Pareja, Luiz Augusto Carneiro D′Albuquerque · 2009 · Obesity Surgery
  23. Management of Nonalcoholic Steatohepatitis
    Suzanne E. Mahady, Jacob George · 2012 · Clinics in Liver Disease
  24. Reversibility of Stricturing Crohnʼs Disease—Fact or Fiction?
    Dominik Bettenworth, Florian Rieder · 2015 · Inflammatory Bowel Diseases
  25. Review article: novel methods for the treatment of non-alcoholic steatohepatitis - targeting the gut immune system to decrease the systemic inflammatory response without immune suppression
    Yaron Ilan · 2016 · Alimentary Pharmacology & Therapeutics
  26. Yo Jyo Hen Shi Ko (YHK) Improves Transaminases in Nonalcoholic Steatohepatitis (NASH): A Randomized Pilot Study
    Nilesh Chande, Maggie Laidlaw, Paul C. Adams, Paul Marotta · 2006 · Digestive Diseases and Sciences
  27. Influence of Metabolic Syndrome, Viral Genotype and Antiviral Therapy on Superimposed Fatty Liver Disease in Chronic Hepatitis C
    Chun‐Jen Liu, Yung‐Ming Jeng, Pei‐Jer Chen, Ming‐Yang Lai, Hung‐Chih Yang, Wen‐Ling Huang, Jia‐Horng Kao, Ding‐Shinn Chen · 2005 · Antiviral Therapy
  28. Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation
    Alberto Quaglia, Venâncio Avancini Ferreira Alves, Charles Paul Balabaud, Prithi S. Bhathal, Paulette Bioulac‐Sage, James M. Crawford, Amar Paul Dhillon, Linda D. Ferrell, Maria Guido, Prodromos Hytiroglou et al. · 2016 · Histopathology
  29. The Mexican consensus on nonalcoholic fatty liver disease
    Raúl Bernal-Reyes, Graciela Castro‐Narro, René Malé-Velázquez, Ramón Carmona-Sánchez, M.S. González-Huezo, Ignacio García-Juárez, Norberto Carlos Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia et al. · 2019 · Revista de Gastroenterología de México (English Edition)
  30. Effect of pronounced weight loss on visceral fat, liver steatosis and adiponectin isoforms
    Julia Engl, Wolfgang Sturm, A. Sandhofer, Susanne Kaser, Alexander Tschoner, T. Tatarczyk, H. Weiss, Herbert Tilg, Josef R. Patsch, Christoph F. Ebenbichler · 2008 · European Journal of Clinical Investigation
  31. Obesity and cancer—extracellular matrix, angiogenesis, and adrenergic signaling as unusual suspects linking the two diseases
    Pellegata, Natalia S., Berriel Diaz, Mauricio, Rohm, Maria, Herzig, Stephan · 2022 · Cancer and Metastasis Reviews
  32. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs
    Ashley S Brown, Zachary D Goodman · 2012 · Expert Review of Gastroenterology & Hepatology
  33. Fatty Liver Disease
    DINA G. TINIAKOS, Quentin Mark Anstee, Alastair D. Burt · 2017 · Elsevier eBooks
  34. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial
    Milad Daneshi‐Maskooni, Seyed Ali Keshavarz, Siavash Mansouri, Mostafa Qorbani, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh · 2017 · Trials
  35. Associates of change in liver fat content in the morbidly obese after laparoscopic gastric banding surgery
    Phillips, M. L., Boase, S., Wahlroos, S., Dugar, M., Kow, L., Stahl, J., Slavotinek, J. P., Valentine, R., Toouli, J., Thompson, C. H. · 2008 · Diabetes, Obesity and Metabolism
  36. Using Transient Elastography to Detect Chronic Liver Diseases in a Primary Care Nurse Consultancy
    Núria Fabrellas, Magda Alemany, Marta Urquizu, Concepció Bartrés, Guillem Pera, Eulàlia Juvé, Lluís Rodríguez, Pere Torán‐Monserrat, Llorenç Caballería · 2013 · Nursing Research
  37. The Impact of Nonalcoholic Fatty Liver Disease in Primary Care: A Population Health Perspective
    Amr Dokmak, Blanca Lizaola‐Mayo, Hirsh D. Trivedi · 2020 · The American Journal of Medicine
  38. The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease
    Derek M. Tang, Sheila Kumar · 2017 · Current Gastroenterology Reports
  39. Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD
    Mohamed Abdalla Salman, Ahmed Salman, Ahmed Abdelsalam, Mohamed Atallah, Hossam El‐Din Shaaban, Ahmed El-Mikkawy, Mahmoud Gouda Omar, Mai Galal Elshenoufy · 2019 · Obesity Surgery
  40. The effect of a multidisciplinary intervention program on hepatic adiposity in overweight-obese children: protocol of the EFIGRO study
    María Medrano, Edurne Maíz, Sara Maldonado‐Martín, Lide Arenaza, Beatriz Rodríguez‐Vigil, Francisco B. Ortega, Jonatan R. Ruiz, Eider Larrarte, Ignacio Díez López, Ainhoa Sarasua-Miranda et al. · 2015 · Contemporary Clinical Trials
  41. Pharmacokinetic study of major bioactive components in rats after oral administration of extract of Ilex hainanensis by high-performance liquid chromatography/electrospray ionization mass spectrometry
    Jie Yang, Fang Lv, Xiao-qing Chen, Wei‐xi Cui, Lihong Chen, Xiaodong Wen, Qiang Wang · 2013 · Journal of Pharmaceutical and Biomedical Analysis
  42. Obesity-related cardiorenal disease: the benefits of bariatric surgery
    Wiebke Fenske, Thanos Athanasiou, Leanne Harling, Christiane Drechsler, Ara Wardkes Darzi, Hutan Ashrafian · 2013 · Nature Reviews Nephrology
  43. Treatment of preestablished diet-induced fatty liver by oral fatty acid–bile acid conjugates in rodents
    Alicia I. Leikin-Frenkel, Ilana Goldiner, Diana Leikin-Gobbi, Ruth A. Rosenberg, Hamutal Bonen, Alex Litvak, Jöelle Bernheim, Fred Meir Konikoff, Tuvia Gilat · 2008 · European Journal of Gastroenterology & Hepatology
  44. Nonalcoholic fatty liver disease and obesity.
    W. Salgado, J. S. dos Santos, A. Sankarankutty, O. de Castro e Silva · 2006 · Acta Cirurgica Brasileira
  45. Nonalcoholic fatty liver disease: the potential role of nutritional management
    Isabelle Anne Leclercq, Yves Horsmans · 2008 · Current Opinion in Clinical Nutrition & Metabolic Care
  46. Nonalcoholic fatty liver disease (NAFLD): Approach in the adolescent patient
    Eve A. Roberts, Jason Y. K. Yap · 2006 · Current Treatment Options in Gastroenterology
  47. Excessive consumption of fructose causes cardiometabolic dysfunctions through oxidative stress and inflammation
    Nathália Bernardes, Prathapan Ayyappan, Kátia De Angelis, Ashim Kumar Bagchi, Gauri Akolkar, Danielle da Silva Dias, Adriane Belló‐Klein, Pawan K. Singal · 2017 · Canadian Journal of Physiology and Pharmacology
  48. Preoperative 4-Week Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Liver Volume and Facilitates Bariatric Surgery in Morbidly Obese Patients
    Antonio Iannelli, Francesco Martini, Anne Sophie Schneck, Bijan Ghavami, Guillaume Baudin, Rodolphe Anty, Jean Gugenheim · 2013 · Obesity Surgery
  49. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study
    Joo Hee Kwak, Dae Won Jun, Seung Min Lee, Yong Kyun Cho, Kang Nyeong Lee, Hang Lak Lee, Oh Young Lee, Ho Soon Choi, Byung Chul Yoon · 2017 · Clinical Nutrition
  50. Evolving trends in nonalcoholic fatty liver disease
    Jorge Delgado · 2008 · European Journal of Internal Medicine
  51. Non‐Alcoholic Fatty Liver and Non‐Alcoholic Steatohepatitis
    Geoffrey C. Farrell · 2007
  52. The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
    Reem Abou Assi, Ibrahim M. Abdulbaqi, Siok Yee Chan · 2021 · Pharmaceuticals
  53. Abnormal liver function in children with metabolic syndrome from a UK-based obesity clinic
    C. Wei, A. Ford, Linda P. Hunt, Elizabeth Clare Crowne, Julian P. Hamilton-Shield · 2010 · Archives of Disease in Childhood
  54. Recommendations for the Evaluation of Pathology Data in Nonclinical Safety Biomarker Qualification Studies
    John E. Burkhardt, Karamjeet Pandher, Phil F. Solter, Sean P. Troth, Rogely Waite Boyce, Tanja S. Zabka, Daniela Ennulat · 2011 · Toxicologic Pathology
  55. Research advances in the diagnosis and treatment of MASLD/MASH
    Dekai Wang, Jinxian Miao, Lihua Zhang, Lin Zhang · 2024 · Annals of Medicine
  56. Magnetic Resonance Imaging of Changes in Abdominal Compartments in Obese Diabetics during a Low-Calorie Weight-Loss Program
    Lena Vogt, Antje Steveling, Peter J. Meffert, Marie‐Luise Kromrey, Rebecca Keßler, Norbert Hosten, Janine Krüger, Simone Gärtner, Ali Alexander Aghdassi, Julia V. Mayerle et al. · 2016 · PLoS ONE
  57. Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis
    Julio Plaza‐Díaz, Patricio Solis‐Urra, Jerónimo Aragón‐Vela, Fernando Rodríguez‐Rodríguez, Jorge Eduardo Olivares Arancibia, Ana I. Álvarez‐Mercado · 2021 · Biomedicines
  58. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis
    Bogdan Dzyubak, Jiahui Li, Jie Chen, Kristin C. Mara, Terry M. Therneau, Sudhakar Kundapur Venkatesh, Richard L. Ehman, Alina M. Allen, Meng Yin · 2021 · Journal of Magnetic Resonance Imaging
  59. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
    Lucía Lavín-Alconero, Tatiana Fernández-Lanas, Paula Iruzubieta, M. Arias, Juan Carlos Rodríguez-Duque, Coral Rivas, María Luisa Cagigal, Coral Montalbán, Antonio López Useros, Ana Álvarez-Cancelo et al. · 2021 · Trials
  60. Predictors of fibrosis in Asian patients with non‐alcoholic steatohepatitis
    Steven Woon Choy Tsang, Wing-Fung Ng, BRIAN PING YING WU, DAVID ALAN CHOW, ERIC TING HO LI, Tak Cheung Wong · 2006 · Journal of Gastroenterology and Hepatology
  61. Nonalcoholic fatty liver disease and bariatric surgery
    Sindu Stephen, Ancha V. Baranova, Zobair M. Younossi · 2012 · Expert Review of Gastroenterology & Hepatology
  62. Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery
    Antônio Ricardo Cardia Ferraz de Andrade, Helma Pinchemel Cotrim, Erivaldo Santos Alves, Daniela Arruda Soares, Raquel Rocha, Alessandro de Moura Almeida, Carolina G. Almeida, Luiz Antônio de Freitas · 2008 · Annals of Hepatology
  63. Toward surface quantification of liver fibrosis progression
    Yuting He, Chiang Huen Kang, Shuoyu Xu, Xiaoye Tuo, Scott Trasti, Dean Tai, Anju Mythreyi Raja, Qiwen Peng, Peter T. C. So, Jagath Chandana Rajapakse et al. · 2010 · Journal of Biomedical Optics
  64. Non-alcoholic fatty liver disease
    Ian Homer Y. Cua, Jacob George · 2005 · British Journal of Hospital Medicine
  65. NASH: a hidden and silent fibroser finally revealed?
    Vlad Ratziu, Thierry Poynard · 2004 · Journal of Hepatology
  66. Safety and efficacy of bariatric surgery in patients with advanced fibrosis
    Tanveer Singh, Gursimran Singh Kochhar, George Boon‐Bee Goh, Philip R. Schauer, Stacy A. Brethauer, Matthew Kroh, Ali Aminian, Rocío López, Srinivasan Dasarathy, Arthur J. McCullough · 2016 · International Journal of Obesity
  67. Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India
    Apurva S. Shah, Deepak Narayan Amarapurkar · 2017 · Journal of Clinical and Experimental Hepatology
  68. The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Daniel Shouhed, Justin A. Steggerda, Miguel A. Burch, Mazen Noureddin · 2017 · Expert Review of Gastroenterology & Hepatology
  69. Legume intake and risk of nonalcoholic fatty liver disease
    Alireza Bahrami, Farshad Teymoori, Tannaz Eslamparast, Golbon Sohrab, Ehsan Hejazi, Hossein Poustchi, Azita Hekmatdoost · 2019 · Indian Journal of Gastroenterology
  70. Triterpenoid-Rich Fraction from Ilex hainanensis Merr. Attenuates Non-Alcoholic Fatty Liver Disease Induced by High Fat Diet in Rats
    Wei‐xi Cui, Jie Yang, Xiao-Qing Chen, Qian Mao, Xiang‐lan Wei, Xiaodong Wen, Qiang Wang · 2013 · The American Journal of Chinese Medicine
  71. A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial
    Fardin Moradi, Fateme Kooshki, Forough Nokhostin, Manouchehr Khoshbaten, Hadi Bazyar, Bahram Pourghassem Gargari · 2020 · Journal of Trace Elements in Medicine and Biology
  72. Development and Regression of Cirrhosis
    Francesca Saffioti, Massimo Pinzani · 2016 · Digestive Diseases
  73. Structure, Function, and Responses to Injury
    James M. Crawford, Paulette Bioulac‐Sage, Prodromos Hytiroglou · 2017 · Elsevier eBooks
  74. Fatty liver disease
    Elizabeth M. Brunt, Brent A. Neuschwander‐Tetri, Alastair D. Burt · 2011 · Elsevier eBooks
  75. The impact of bariatric surgery on nonalcoholic fatty liver disease
    A. C. D. de Freitas, A. C. Campos, J. C. Coelho · 2008 · Current opinion in clinical nutrition and metabolic care
  76. Bariatric surgery and nonalcoholic fatty liver disease
    Guy Bower, Thanos Athanasiou, Alberto Isla, Leanne Harling, Jia V. Li, Elaine C. Holmes, Evangelos Efthimiou, Ara Wardkes Darzi, Hutan Ashrafian · 2015 · European Journal of Gastroenterology & Hepatology
  77. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD)
    Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, Emilio Molina‐Molina, Harshitha Shanmugam, Gabriella Garruti, David Q.‐H. Wang, Piero Portincasa · 2021 · Methods in molecular biology
  78. Nonalcoholic Fatty Liver Disease: A Nutritional Approach
    Yaşar Çolak, İlyas Tuncer, Ebubekir Şenateş, Oğuzhan Öztürk, Hamdi Levent Doğanay, Yusuf Nadir Yilmaz · 2012 · Metabolic Syndrome and Related Disorders
  79. Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation
    Yizhe Cui, Qiuju Wang, Xiaochong Li, Xiuying Zhang · 2013 · Redox Biology
  80. Laparoscopic Adjustable Gastric Banding In Patients with Unexpected Cirrhosis: Safety and Outcomes
    Richard M. Woodford, Paul Robert Burton, Paul E. O’Brien, Cheryl Laurie, Wendy A. Brown · 2015 · Obesity Surgery
  81. Bioconjugation of Oligonucleotides for Treating Liver Fibrosis
    Zhaoyang Ye, Houssam S. Hajj Houssein, Ram I. Mahato · 2007 · Oligonucleotides
  82. The role of laminin–integrin signaling in triggering MB formation. An in vivo and in vitro study
    Yong Wu, Nan Li, Fawzia Bardag‐Gorce, Jun Li, Barbaba A. French, La Toyia Wilson, Jennifer Dedes, Samuel William French · 2005 · Experimental and Molecular Pathology
  83. Long-term effect of bariatric surgery on resolution of nonalcoholic steatohepatitis (NASH): An external validation and application of a clinical NASH score
    Chun Hai Tan, Nawaf Al-Kalifah, Kong‐Han Ser, Yi-Chih Lee, Jung‐Chien Chen, Wei‐Jei Lee · 2018 · Surgery for Obesity and Related Diseases
  84. Protective Effects of Evening Primrose Oil against Cyclophosphamide-Induced Biochemical, Histopathological, and Genotoxic Alterations in Mice
    Dina M. Khodeer, Eman T. Mehanna, Abdelrahman Ibrahim Abushouk, Mohamed M. Abdel‐Daim · 2020 · Pathogens
  85. Nonalcoholic Steatohepatitis and the Cardiometabolic Syndrome
    Mohammad Basem Abdeen, Nazif A. Chowdhury, Melvin Ray Hayden, Jamal A. Ibdah · 2006 · Journal of the CardioMetabolic Syndrome
  86. Effects of Canagliflozin on Hepatic Steatosis, Visceral Fat and Skeletal Muscle among Patients with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease
    Noriko Nishimiya, Kazuki Tajima, Kento Imajo, Akiko Kameda, Eiko Yoshida, Yu Togashi, Kazutaka Aoki, Tomio Inoue, Atsushi Nakajima, Daisuke Utsunomiya et al. · 2021 · Internal Medicine
  87. Effectiveness of the pomegranate extract in improving hepatokines and serum biomarkers of non-alcoholic fatty liver disease: A randomized double blind clinical trial
    Sima Jafarirad, Reza Goodarzi, Narges Mohammadtaghvaei, Maryam Dastoorpoor, Pejman Alavinejad · 2022 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  88. Emerging drugs for non-alcoholic fatty liver disease
    Alessandro Federico, Marco Niosi, C. Del Vecchio Blanco, C. Loguercio · 2008 · Expert Opinion on Emerging Drugs
  89. The treatment of NAFLD.
    M. Trappoliere, Concetta Tuccillo, Alessandro Federico, Di Leva A., Marco Niosi, Carmela D’Alessio, Rita Capasso, F Coppola, M.V. D’Auria, C. Loguercio · 2005 · PubMed
  90. Nonalcoholic fatty liver disease and bariatric surgery in adolescents
    Ai‐Xuan Holterman, Juan Pablo Gurria, Smita Tanpure, Nerina M. DiSomma · 2013 · Seminars in Pediatric Surgery
  91. Prevention and treatment of nonalcoholic fatty liver disease
    Giovanni Targher, Alessandro Bellis, Paolo Fornengo, Maria Francesca Ciaravella, Isabella Pichiri, Paolo Cavallo Perin, Bruno Trimarco, Giulio Marchesini · 2010 · Digestive and Liver Disease
  92. Nonalcoholic Fatty Liver Disease
    Samer Gawrieh · 2016 · Springer eBooks
  93. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease
    P Riley, J. O’Donohue, M.A. Crook · 2007 · Journal of Clinical Pathology
  94. Review: Advances in the treatment of nonalcoholic fatty liver disease
    Sanjeev R. Mehta · 2010 · Therapeutic Advances in Endocrinology and Metabolism
  95. Liver Injury and Acute Liver Failure After Bariatric Surgery
    Laura R. Moolenaar, Nadine E. de Waard, Michal Heger, Lianne R. de Haan, Caline P.J. Slootmaekers, Willemijn N. Nijboer, Maarten E. Tushuizen, Rowan F. van Golen · 2022 · Journal of Clinical Gastroenterology
  96. The Decrease of Serum Levels of Human Neutrophil Alpha-Defensins Parallels with the Surgery-Induced Amelioration of NASH in Obesity
    Melania Manco, José Manuel Fernández‐Real, Fabio Maria Vecchio, Valerio Gaetano Vellone, José María Moreno‐Navarrete, Vincenzo Tondolo, GianFranco Bottazzo, G Nanni, Geltrude Mingrone · 2010 · Obesity Surgery
  97. Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction
    Sherin Elsa Mathews, Rekha B. Kumar, Alpana P. Shukla · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
  98. Results of Bariatric Surgery
    Erik Nathan Hansen, Alfonso Torquati, Naji N. Abumrad · 2006 · Annual Review of Nutrition
  99. The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis
    Jozef Urdzik, Tomas Bjerner, Alkwin Wanders, Ján Weis, FRANS F. DURAJ, U Haglund, Agneta Norén · 2011 · Journal of Hepatology
  100. Future therapy of portal hypertension in liver cirrhosis – a guess
    Tilman Sauerbruch, Jonel Trebicka · 2014 · F1000Prime Reports